← Portfolio Scout

Portfolio company

MaxCyte

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechDigital Health

About

MaxCyte provides cell-engineering electroporation platforms and gene-editing assessment services for biopharmaceutical companies, research institutions and therapy developers.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies